Lack of Conventional Acinar Cells in Parotid Salivary Gland of Patient Taking an Anti-PD-L1 Immune Checkpoint Inhibitor

Background: Salivary glands (SGs) can be damaged by immune checkpoint inhibitor (ICI) therapy. In patients with ICI-induced SG dysfunction, 60% progress to fulfill classification criteria for primary Sjögren's syndrome (pSS), owing to immune foci in SGs and/or anti-SSA autoantibody positivity....

Descripción completa

Detalles Bibliográficos
Autores principales: Pringle, Sarah, van der Vegt, Bert, Wang, Xiaoyan, van Bakelen, Nico, Hiltermann, T. Jeroen N., Spijkervet, Fred K. L., Vissink, Arjan, Kroese, Frans G. M., Bootsma, Hendrika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142242/
https://www.ncbi.nlm.nih.gov/pubmed/32300556
http://dx.doi.org/10.3389/fonc.2020.00420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142242/
https://www.ncbi.nlm.nih.gov/pubmed/32300556
http://dx.doi.org/10.3389/fonc.2020.00420

Ejemplares similares